Leuthold Group, LLC Pfizer Inc Transaction History

Leuthold Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $111,646 - $129,172	-3,091 Reduced 3.2%	93,443 $3.43 Million
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $3.46 Million - $4.5 Million	87,773 Added 1001.86%	96,534 $3.94 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $6,304 - $8,229	-151 Reduced 1.69%	8,761 $449,000
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $6.57 Million - $8.02 Million	-150,047 Reduced 94.39%	8,912 $390,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $1.28 Million - $1.52 Million	27,592 Added 21.0%	158,959 $8.33 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $6.01 Million - $7.45 Million	131,367 New	131,367 $6.8 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $351,535 - $447,007	-10,503 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $9,271 - $10,877	-292 Reduced 2.7%	10,503 $385,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $12,740 - $15,456	-423 Reduced 3.77%	10,795 $353,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $28,165 - $40,242	-1,042 Reduced 8.5%	11,218 $366,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $403,599 - $458,033	12,260 New	12,260 $480,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.